(Press-News.org) PITTSBURGH, Feb. 8, 2013 – Genes that have roles in the same biological pathways change their rate of evolution in parallel, a finding that could be used to discover their functions, said a researcher at the University of Pittsburgh School of Medicine in the February issue of GENETICS.
Humans have nearly 21,000 genes that make as many proteins, but the functions of most of those genes have not been fully determined, said lead investigator Nathan Clark, Ph.D., assistant professor of computational and systems biology at the Pitt School of Medicine. Knowing what a particular gene does could help unravel the workings of the body, foster understanding of disease processes and identify targets for new drugs.
"For our study, we took a close look at the way genes evolved between species and we found an interesting signature," he said. "Genes that perform biological functions together have similar evolutionary histories in that the rates at which they change parallel each other. This could allow us to identify partner genes that we might never have suspected to work together in biochemical pathways."
The researchers studied the evolving genomes of 18 yeast species and 22 mammalian species, looking particularly at genes that are involved in meiosis, a cell division process, and in DNA repair. They found parallel changes, such as acceleration or deceleration, in evolutionary rates among not only genes encoding proteins that physically interact with each other, but also among those that had no direct contact but still participated in meiosis or DNA repair pathways.
All genes mutate over time, which can be beneficial, harmful or meaningless. Some yeast species evolved a different method of reproduction and meiosis stopped as it was no longer essential for survival, Dr. Clark said. Through subsequent generations, the rate of change in the genes involved in making meiosis proteins accelerated, leading to deterioration of the unnecessary DNA sequences.
"A key question is: How important is that gene at that time?" he said. "If a species encounters a new challenge in its environment, the genes associated with it might have to evolve through subsequent generations in order to adapt that important pathway and ensure species survival."
By tracking those complementary rate changes, it could be possible to identify which genes participate in the same important pathways, providing clues to their function.
"In the future, a researcher studying a particular disease process might be able to plug in a couple of known genes in a database of evolutionary rate changes to find others that have a parallel history," Dr. Clark said. "That could provide new insight into the workings of the biological pathway of interest."
###
The paper's other authors are Eric Alani, Ph.D., and Charles F. Aquadro, Ph.D., both of Cornell University. The project was supported by National Institutes of Health grants GM53085 and GM36431.
Contact: Susan Manko
Phone: 412-586-9771
E-mail: MankoSM@upmc.edu
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see www.medschool.pitt.edu.
http://www.upmc.com/media
END
WASHINGTON – The first randomized controlled study to evaluate a procedure that removes blood clots in the brain from patients experiencing severe strokes finds it delivers no better outcomes than non-invasive standard medications. In addition, the study found imaging techniques were not helpful in identifying patients who potentially would benefit most from clot removal.
The study, led by a Georgetown University Medical Center researcher, was published online today in the New England Journal of Medicine and simultaneously presented at the International Stroke Conference ...
The use of advanced imaging shortly after the onset of acute stroke failed to identify a subgroup of patients who could benefit from a clot-removal procedure, a study has found.
The randomized controlled trial known as Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) was funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and was published online Feb. 8 in the New England Journal of Medicine.
In patients with ischemic stroke (caused by a blockage in an artery), ...
People are bombarded with claims in newspapers and on the internet that are based on scientific studies. When faced with a headline that suggests an Alzheimer's drug increases the risk of heart attack or that watching TV is bad for children's mental health, or that pesticides are causing a decline in bee populations, people have to work out what to believe. Which claims should be taken seriously? Which are 'scares'?
I Don't Know What to Believe: Making Sense of Science Stories... explains the peer review process – the system researchers use to assess the validity, significance ...
PITTSBURGH, Feb. 8, 2013 – Researchers at the University of Pittsburgh School of Medicine and UPMC describe in PLoS ONE how an electrode array sitting on top of the brain enabled a 30-year-old paralyzed man to control the movement of a character on a computer screen in three dimensions with just his thoughts. It also enabled him to move a robot arm to touch a friend's hand for the first time in the seven years since he was injured in a motorcycle accident.
With brain-computer interface (BCI) technology, the thoughts of Tim Hemmes, who sustained a spinal cord injury that ...
HOUSTON - Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.
"After surgery, with or without pre-surgical chemotherapy, when low-grade serous ovarian cancer persists or returns, chemotherapy and hormonal therapy are relatively ineffective," said David Gershenson, M.D., professor in The University of Texas MD Anderson Cancer Center Department of Gynecological Oncology and Reproductive Medicine.
Response rates for treatment are measured in single digits. Gershenson ...
Highlights
Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood.
The findings provide valuable information for dialysis patients and their physicians.
Approximately 2 million patients in the world receive dialysis treatments.
Washington, DC (February 7, 2013) — Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood, requiring patients to undergo more repair procedures to the site through which blood is removed and returned, according to a study ...
Highlight
Adding fruits and vegetables to the diet is an effective alternative to medication to reduce metabolic acidosis and kidney injury in late-stage chronic kidney disease.
Metabolic acidosis is a common complication of kidney disease.
Washington, DC (February 7, 2013) — Adding fruits and vegetables to the diet may help protect the kidneys of patients with chronic kidney disease (CKD) with too much acid build-up, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
Western diets that are ...
An international team of researchers has reconstructed the common ancestor of placental mammals—an extremely diverse group including animals ranging from rodents to whales to humans—using the world's largest dataset of both genetic and physical traits. In research to be published in the journal Science, the scientists reveal that, contradictory to a commonly held theory, placental mammals did not diversify into their present-day lineages until after the extinction event that eliminated non-avian dinosaurs, and about 70 percent of all species on Earth, some 65 million years ...
The demise of the dinosaurs is the world's ultimate whodunit. Was it a comet or asteroid impact? Volcanic eruptions? Climate change?
In an attempt to resolve the issue, scientists at the Berkeley Geochronology Center (BGC), the University of California, Berkeley, and universities in the Netherlands and the United Kingdom have now determined the most precise dates yet for the dinosaur extinction 66 million years ago and for the well-known impact that occurred around the same time.
The dates are so close, the researchers say, that they now believe the comet or asteroid, ...
Pittsburgh, Pennsylvania…A groundbreaking six-year research collaboration has produced the most complete picture yet of the evolution of placental mammals, the group that includes humans. Placental mammals are the largest branch of the mammalian family tree, with more than 5,100 living species. Researchers from Carnegie Museum of Natural History are among the team of 23 that took part in this extensive interdisciplinary effort that utilizes molecular (DNA) and morphological (anatomy) data on an extraordinary scale. By combining these two types of data scientists reconstructed, ...
